Sage Therapeutics to Host Sage FutureCast Webcast
August 20 2020 - 4:31PM
Business Wire
Sage Therapeutics, Inc. (NASDAQ:SAGE), a
biopharmaceutical company committed to developing novel therapies
with the potential to transform the lives of people with
debilitating disorders of the brain, today announced that it will
host Sage FutureCast: An R&D and Portfolio Review on Thursday,
September 10, 2020 from 9:00 a.m. to 11:00 a.m. ET.
Sage FutureCast will discuss the Company’s research and
development strategy, and review clinical progress in programs
throughout the depression, neurology and neuropsychiatric
franchises, including zuranolone, SAGE-324 and SAGE-718,
respectively.
A live webcast of the presentation can be accessed on the
investor page of Sage's website at investor.sagerx.com. A replay of
the webcast will also be archived for up to 30 days on Sage's
website following the conference.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company committed to
developing novel therapies with the potential to transform the
lives of people with debilitating disorders of the brain. We are
pursuing new pathways with the goal of improving brain health, and
our depression, neurology and neuropsychiatry franchise programs
aim to change how brain disorders are thought about and treated.
Our mission is to make medicines that matter so people can get
better, sooner. For more information, please visit
www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200820005777/en/
Investor Contact Jeff Boyle 617-949-4256
Jeff.Boyle@sagerx.com
Media Contact Maureen L. Suda 617-949-4289
maureen.suda@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Sep 2023 to Sep 2024